blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1417222

EP1417222 - ISOLATED POLYPEPTIDES BASED ON THE NEUTRALIZING EPITOPE OF THE P17 PROTEIN OF HIV USEFUL AS VACCINES, AND NEUTRALIZING ANTI-P17 ANTIBODIES WHICH SPECIFICALLY RECOGNIZE SAID NEUTRALIZING EPITOPE [Right-click to bookmark this link]
Former [2004/20]ISOLATED POLYPEPTIDES BASED ON THE NEUTRALIZING EPITOPE OF THE P17 PROTEIN OF HIV USEFUL AS VACCINES, AND NEUTRALZING ANNTI-P17 ANTIBODIES WHICH SPECIFICALLY RECOGNIZE SAID NEUTRALIZING EPITOPE
[2010/33]
StatusNo opposition filed within time limit
Status updated on  24.06.2011
Database last updated on 29.07.2024
Most recent event   Tooltip24.06.2011No opposition filed within time limitpublished on 27.07.2011  [2011/30]
Applicant(s)For all designated states
Medestea Research & Production S.p.A.
Via Ribes, 5
10010 Colleretto Giacosa (TO) / IT
[N/P]
Former [2010/50]For all designated states
Medestea Research & Production S.p.A.
Via Ribes 5
10010 Colleretto Giacosa (Torino) / IT
Former [2010/28]For all designated states
Medestea Internazionale S.p.A.
Via Cernaia 31
10121 Torino / IT
Former [2004/20]For all designated states
Medestea Internazionale S.r.l.
Via Magenta 43
I- 10128 Torino / IT
Inventor(s)01 / CARUSO, Arnaldo
Via Daniele Comboni 19
I-25123 Brescia / IT
02 / FRANZONE, José, Sebastian
Via Maria Vittoria 23
I-10123 Torino / IT
 [2004/20]
Representative(s)Comoglio, Elena, et al
Jacobacci & Partners S.p.A.
Corso Emilia 8
10152 Torino / IT
[N/P]
Former [2008/02]Comoglio, Elena, et al
Jacobacci & Partners S.p.A Corso Emilia, 8
10152 Torino / IT
Former [2004/20]Rambelli, Paolo, et al
c/o JACOBACCI & PERANI S.p.A. Corso Regio Parco, 27
10152 Torino / IT
Application number, filing date02751526.105.08.2002
[2004/20]
WO2002IB03093
Priority number, dateIT2001TO0079507.08.2001         Original published format: IT TO20010795
IT2001TO0104202.11.2001         Original published format: IT TO20011042
[2004/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03016337
Date:27.02.2003
Language:EN
[2003/09]
Type: A1 Application with search report 
No.:EP1417222
Date:12.05.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 27.02.2003 takes the place of the publication of the European patent application.
[2004/20]
Type: B1 Patent specification 
No.:EP1417222
Date:18.08.2010
Language:EN
[2010/33]
Search report(s)International search report - published on:EP27.02.2003
ClassificationIPC:C07K7/08, C07K14/16, A61K38/10, A61P31/18
[2004/20]
CPC:
B82Y5/00 (EP,US); A61K47/6898 (EP,US); A61P31/18 (EP);
C07K14/005 (EP,US); C07K14/43595 (EP,US); A61K38/00 (EP,US);
C12N2740/16222 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/20]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ISOLIERTE POLYPEPTIDE AUF DER GRUNDLAGE DES NEUTRALISIERENDEN EPITOPS DES P17-PROTEINS VOM HIV GEEIGNET ALS IMPFSTOFFE UND NEUTRALISIERENDE ANTI-P17-ANTIKÖRPER, DIE BESAGTES EPITOP SPEZIFISCH ERKENNEN[2004/20]
English:ISOLATED POLYPEPTIDES BASED ON THE NEUTRALIZING EPITOPE OF THE P17 PROTEIN OF HIV USEFUL AS VACCINES, AND NEUTRALIZING ANTI-P17 ANTIBODIES WHICH SPECIFICALLY RECOGNIZE SAID NEUTRALIZING EPITOPE[2010/33]
French:POLYPEPTIDES ISOLES SUR LA BASE DE L'EPITOPE DE NEUTRALISATION DE LA PROTEINE P17 DU VIH UTILES COMME VACCINS, ET ANTICORPS ANTI-P17 DE NEUTRALISATION RECONNAISSANT LEDIT EPITOPE DE NEUTRALISATION DE MANIERE SPECIFIQUE[2004/20]
Former [2004/20]ISOLATED POLYPEPTIDES BASED ON THE NEUTRALIZING EPITOPE OF THE P17 PROTEIN OF HIV USEFUL AS VACCINES, AND NEUTRALZING ANNTI-P17 ANTIBODIES WHICH SPECIFICALLY RECOGNIZE SAID NEUTRALIZING EPITOPE
Entry into regional phase04.03.2004National basic fee paid 
04.03.2004Designation fee(s) paid 
04.03.2004Examination fee paid 
Examination procedure06.03.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
04.03.2004Examination requested  [2004/20]
19.07.2007Despatch of a communication from the examining division (Time limit: M04)
20.11.2007Reply to a communication from the examining division
23.09.2008Despatch of a communication from the examining division (Time limit: M04)
22.01.2009Reply to a communication from the examining division
26.02.2010Communication of intention to grant the patent
25.06.2010Fee for grant paid
25.06.2010Fee for publishing/printing paid
Opposition(s)19.05.2011No opposition filed within time limit [2011/30]
Fees paidRenewal fee
13.07.2004Renewal fee patent year 03
15.07.2005Renewal fee patent year 04
20.06.2006Renewal fee patent year 05
20.06.2007Renewal fee patent year 06
25.06.2008Renewal fee patent year 07
23.06.2009Renewal fee patent year 08
22.06.2010Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT18.08.2010
BE18.08.2010
CY18.08.2010
CZ18.08.2010
EE18.08.2010
FI18.08.2010
SK18.08.2010
BG18.11.2010
GR19.11.2010
[2011/23]
Former [2011/17]AT18.08.2010
BE18.08.2010
CY18.08.2010
FI18.08.2010
BG18.11.2010
GR19.11.2010
Former [2011/15]AT18.08.2010
CY18.08.2010
FI18.08.2010
BG18.11.2010
GR19.11.2010
Former [2011/13]AT18.08.2010
CY18.08.2010
FI18.08.2010
BG18.11.2010
Former [2011/11]AT18.08.2010
FI18.08.2010
BG18.11.2010
Former [2011/10]AT18.08.2010
FI18.08.2010
Former [2011/08]AT18.08.2010
Cited inInternational search[A]EP0426314  (VIRAL TECHNOLOGIES INC [US], et al) [A] 1-19 * the whole document *;
 [A]EP0620009  (VIRAL TECHNOLOGIES INC [US], et al) [A] 1-19 * the whole document *;
 [A]US6268472  (ZIMMERMAN DANIEL H [US], et al) [A] 1-19 * the whole document *;
 [A]  - BURATTI EMANUELE ET AL, "A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE.", JOURNAL OF VIROLOGY, (1997), vol. 71, no. 3, ISSN 0022-538X, pages 2457 - 2462, XP002227397 [A] 1-19 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.